[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"laser-induced-hyperpigmentation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:laser-induced-hyperpigmentation":47},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":14,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":5},"100467144",false,"NCT05362929","Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color","Inclusion Criteria:\n\n* Healthy males and females, ≥ 18 years of age at time of informed consent, seeking treatment for acne scarring\n* Subject must voluntarily sign and date an IRB approved informed consent form\n* Subjects with diagnosis of acne scarring recorded over the past 6 months\n* Able to read, understand and voluntarily provide written informed consent.\n* Subject is determined to be healthy, non-smoker\n* Subjects able and willing to comply with the treatment protocol and follow-up schedule and requirements.\n* Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period.\n\nExclusion Criteria:\n\n* Subjects does not have the capacity to consent to the study\n* subject underwent any acne scar treatments in the past 6 months prior to enrollment in the study\n* Subject has active papulopustular or cystic acne within the past 6 months.\n* Any history of keloidal scarring.\n* Any previous surgical procedure in the treatment area in the past 12 months, or major surgery in the last 6 months.\n* History of immunosuppression\u002Fimmune deficiency disorders (including AIDS and HIV infection), and\u002For any history of systemic chemotherapy for prior 12 months.\n* History or current use of the following prescription medications:\n\nImmunosuppressive medications\u002Fbiologics, 6 months prior to and during the study\n\n* Accutane or other systemic retinoids within the past twelve months\n* Smoking or vaping in the past 12 months.\n* History of photosensitivity and\u002For connective tissue disease\n* History of hyperlipidemia, diabetes mellitus, hepatitis, or bleeding disorders.\n* History of major depressive disorders or endocrine disorders including but not limited to; hypothyroidism, Hashimoto's thyroiditis, or hyperthyroidism.\n* History of ongoing pregnancy, active breastfeeding, cancer, and epilepsy",true,"ALL","18 Years",{"count":18,"type":19},46,"ESTIMATED","INTERVENTIONAL",[22],"NA","The investigators aim to investigate the efficacy and tolerability of a hybrid non-ablative\u002Fablative laser for acne scarring in skin of color.",[25,26,27],"Acne Scars - Mixed Atrophic and Hypertrophic","Hyperpigmentation","Laser-Induced Hyperpigmentation",[29,30,31,32,33,34],"skin of color","fitzpatrick skin type III","fitzpatrick skin type IV","fitzpatrick skin type V","acne scarring","sciton","RECRUITING","2025-05-20",{"date":38,"type":39},"2025-05-22","ACTUAL",{"date":41,"type":39},"2023-10-11",{"date":43,"type":19},"2026-09",{"name":45,"class":46},"Albert Einstein College of Medicine","OTHER",""]